Last reviewed · How we verify
NCT06802549
Outcomes of Partial Pulpotomy Treatment in Cariously Exposed Teeth
Phase 4 trial testing Biodentine (calcium silicate-based cement) (Septodont, Saint Maur de Fossés, France) in Deep Dental Caries in 61 participants. Completed in 20 June 2025.
15 June 2025
Quick facts
| Lead sponsor | Firat University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 61 |
| Start date | 20 March 2024 |
| Primary completion | 15 June 2025 |
| Estimated completion | 20 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Biodentine (calcium silicate-based cement) (Septodont, Saint Maur de Fossés, France)
- Theracal PT (resin modified calcium silicate-based cement) (Bisco Inc., Schaumburg, IL, USA)
Conditions studied
- Deep Dental Caries — all drugs for Deep Dental Caries →
Sponsor
Firat University
Who can join
Adults 18 to 50, any sex, with Deep Dental Caries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this clinical trial is to learn how successful Biodentine and Theracal PT dental filling materials are in treating deep tooth decay in adults. It will also provide information about post-treatment pain. The main questions it aims to answer are: Do Biodentine and Theracal PT dental filling materials treat exposed tooth decay in participants? Do they reduce the need for root canal treatment? After the application of Biodentine and Theracal PT dental filling materials to the participants, the pain and symptoms that cause pain may not decrease. In this case, the tooth may be treated with root canal treatment. The researchers will compare the clinical success of Biodentine and Theracal PT dental filling materials with each other. Participants will undergo a single-session partial pulpotomy treatment with the dental filling materials mentioned above. Clinical and radiographic follow-ups will then be performed at 3, 6 and 12 months, and records will be kept.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06802549
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biodentine (calcium silicate-based cement) (Septodont, Saint Maur de Fossés, France)
Trials testing the same drug.
- NCT06802536 — Outcomes of Full Pulpotomy Treatment in Teeth With Symptoms of Irreversible Pulpitis · Phase 4 · active not recruiting
Other recruiting trials for Deep Dental Caries
Currently open trials in the same condition.
- NCT07041905 — Effects of Total and Selective Caries Removal - Requiring or Avoiding Vital Pulp Therapy - on Pulp Vitality and Postoper · NA · recruiting
Other Firat University trials
Trials by the same sponsor.
- NCT07520799 — The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Pati · NA · not yet recruiting
- NCT07520773 — Therapeutic Touch on Sleep, Comfort, and Physiological Parameters in Intensive Care Patients · NA · not yet recruiting
- NCT07521995 — Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in · NA · not yet recruiting
- NCT07520812 — Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multip · NA · not yet recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06802549 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Firat University
- Last refreshed: 23 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06802549.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing